Title : Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis.

Pub. Date : 2013 Nov

PMID : 24011632






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: The result showed that RE of gefitinib at the concentrations of 1 muM and 10 muM was 4.12 and 4.05, respectively, but significantly decreased to 1 and 1.35 after adding a P-glycoprotein (P-gp) inhibitor, cyclosporine A. Gefitinib phosphoglycolate phosphatase Mus musculus
2 RESULTS: The result showed that RE of gefitinib at the concentrations of 1 muM and 10 muM was 4.12 and 4.05, respectively, but significantly decreased to 1 and 1.35 after adding a P-glycoprotein (P-gp) inhibitor, cyclosporine A. Gefitinib phosphoglycolate phosphatase Mus musculus
3 CONCLUSION: Gefitinib is a P-gp substrate and has limited active BBB penetration. Gefitinib phosphoglycolate phosphatase Mus musculus